Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Lampropoulos Justin J.	2. Issuer Name and Ticker or Trading Symbol MERIT MEDICAL SYSTEMS INC [ MMSI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) PRESIDENT, EMEA
(Last) (First) (Middle) 1600 WEST MERIT PARKWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 2/26/2021
(Street) SOUTH JORDAN, UT 84095 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, No Par Value	2/26/2021		A		3315 ⁽¹⁾	A	$0	3315	D
Common Stock, No Par Value	2/26/2021		F		972	D	$55.72	2343	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-qualified stock options (right to buy)	$12.06							10/4/2015 ⁽²⁾	10/4/2021	Common Stock	5000 ⁽³⁾		5000 ⁽⁴⁾	D
Non-qualified stock options (right to buy)	$17.27							2/13/2016 ⁽⁵⁾	2/13/2022	Common Stock	20000		20000	D
Non-qualified stock options (right to buy)	$16.05							1/28/2017 ⁽⁶⁾	1/28/2023	Common Stock	20000		20000	D
Non-qualified stock options (right to buy)	$28.20							4/14/2018 ⁽⁷⁾	4/14/2024	Common Stock	25000		25000	D
Non-qualified stock options (right to buy)	$44.80							3/2/2019 ⁽⁸⁾	3/2/2025	Common Stock	20000		20000	D
Non-qualified stock options (right to buy)	$55.73							3/1/2020 ⁽⁹⁾	3/1/2026	Common Stock	30000		30000	D
Non-qualified stock options (right to buy)	$37.71							2/26/2021 ⁽¹⁰⁾	2/26/2027	Common Stock	16722		16722	D

Explanation of Responses:
(1)	These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020.
(2)	Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
(3)	The number of securities underlying these stock options was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
(4)	The number of securities beneficially owned was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
(5)	Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
(6)	Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
(7)	Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018
(8)	Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
(9)	Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
(10)	Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Lampropoulos Justin J. 1600 WEST MERIT PARKWAY SOUTH JORDAN, UT 84095			PRESIDENT, EMEA